When should factorial designs be used for late-phase randomised controlled trials?

White, Ian R; Szubert, Alexander J; Choodari-Oskooei, Babak; Walker, A Sarah; Parmar, Mahesh Kb

White, Ian R; Szubert, Alexander J; Choodari-Oskooei, Babak; Walker, A Sarah; Parmar, Mahesh Kb.

Affiliation

White IR; MRC Clinical Trials Unit at UCL, London, UK.
Szubert AJ; MRC Clinical Trials Unit at UCL, London, UK.
Choodari-Oskooei B; MRC Clinical Trials Unit at UCL, London, UK.
Walker AS; MRC Clinical Trials Unit at UCL, London, UK.
Parmar MK; MRC Clinical Trials Unit at UCL, London, UK.

Clin Trials ; 21(2): 162-170, 2024 04.

Article in En | MEDLINE | ID: mdl-37904490

Subject(s)

Research Design; Humans; Sample Size; Randomized Controlled Trials as Topic

Key words

Randomised controlled trial; clinical trial; design; factorial

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Research Design Limits: Humans Language: En Journal: Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2024 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google